Literature DB >> 6705155

The effect of two different diltiazem treatments on infarct size in ischemic, reperfused porcine hearts.

H H Klein, M Schubothe, K Nebendahl, H Kreuzer.   

Abstract

The effect of diltiazem on the development of infarcts was investigated in porcine hearts. The left anterior descending coronary artery was occluded in each of 32 anesthetized pigs for 75 min and was reperfused for 4 hr. Diltiazem (15 micrograms/kg X min) was infused in 11 pigs for 30 min before occlusion (therapy A) and in another eight pigs before reperfusion (therapy B). Eleven pigs served as controls. Tissue concentrations of adenosine triphosphate (ATP) and nicotinamide adenine dinucleotide (NAD) were determined in transmural needle biopsy samples taken from the ischemic apex after 70 min of ischemia. The infarct size, expressed as the ratio of the infarcted tissue over the area at risk of necrosis multiplied by 100, amounted to 79 +/- 20% in the control group. Although there was no significant difference between hemodynamics in the control and the treated groups, pretreatment with diltiazem significantly reduced infarct size (53 +/- 26%; p = .025). Reduction of infarct size by therapy B did not reach the required level of significance (66 +/- 33%). The ischemic loss of ATP and NAD was significantly lower in the pretreated group, which further indicates that the beneficial effect of diltiazem was exerted primarily during ischemia and not during reperfusion.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6705155     DOI: 10.1161/01.cir.69.5.1000

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  12 in total

Review 1.  Diltiazem. A reappraisal of its pharmacological properties and therapeutic use.

Authors:  M M Buckley; S M Grant; K L Goa; D McTavish; E M Sorkin
Journal:  Drugs       Date:  1990-05       Impact factor: 9.546

2.  Effects of felodipine on the ischemic heart: insight into the mechanism of cytoprotection.

Authors:  R Ferrari; A Cargnoni; P Bernocchi; G Gaia; M Benigno; E Pasini; P Pedersini; C Ceconi
Journal:  Cardiovasc Drugs Ther       Date:  1996-09       Impact factor: 3.727

3.  Effect of D-600 on ischemic and reperfused rabbit myocardium: relation with timing and modality of administration.

Authors:  R Ferrari; G M Boffa; C Ceconi; S Curello; A Boraso; S Ghielmi; A Cargnoni
Journal:  Basic Res Cardiol       Date:  1989 Nov-Dec       Impact factor: 17.165

Review 4.  Basic mechanisms involved in the protection of the ischaemic myocardium. The role of calcium antagonists.

Authors:  W G Nayler
Journal:  Drugs       Date:  1991       Impact factor: 9.546

Review 5.  Protective effects of calcium antagonists against ischaemia and reperfusion damage.

Authors:  R Ferrari; O Visioli
Journal:  Drugs       Date:  1991       Impact factor: 9.546

6.  Postischemic cell death in reperfused porcine hearts is not attenuated by the spin trap agent PBN during early reperfusion.

Authors:  H H Klein; A Stier; S Pich; D Gehrke; K Nebendahl; S Lindert-Heimberg; C Schade-Brittinger; R Fröde; J Schaper
Journal:  Basic Res Cardiol       Date:  1993 May-Jun       Impact factor: 17.165

Review 7.  Nitric oxide homeostasis as a target for drug additives to cardioplegia.

Authors:  B K Podesser; S Hallström
Journal:  Br J Pharmacol       Date:  2007-05-08       Impact factor: 8.739

8.  Diltiazem treatment for the management of ischaemia in patients with poor left ventricular function: safety of long term administration.

Authors:  M J Zema; S Perlmutter; S Mankes; C Nikitopoulos
Journal:  Br Heart J       Date:  1987-11

9.  Intracoronary hyperosmotic mannitol during reperfusion does not affect infarct size in ischemic, reperfused porcine hearts.

Authors:  H H Klein; K Nebendahl; M Schubothe; H Kreuzer
Journal:  Basic Res Cardiol       Date:  1985 May-Jun       Impact factor: 17.165

10.  Effect of lacidipine on ischaemic and reperfused isolated rabbit hearts.

Authors:  A Boraso; A Cargnoni; L Comini; G Gaia; P Bernocchi; R Ferrari
Journal:  Mol Cell Biochem       Date:  1993-08-11       Impact factor: 3.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.